The news this morning that Athenex has scored $100 million in new investment is another sign that big things are coming for the Buffalo-based developer of cancer therapies.
The news this morning that Athenex has scored $100 million in new investment is another sign that big things are coming for the Buffalo-based developer of cancer therapies.